...
首页> 外文期刊>BioMed research international >Mitoxantrone Loaded Superparamagnetic Nanoparticles for Drug Targeting: A Versatile and Sensitive Method for Quantification of Drug Enrichment in Rabbit Tissues Using HPLC-UV
【24h】

Mitoxantrone Loaded Superparamagnetic Nanoparticles for Drug Targeting: A Versatile and Sensitive Method for Quantification of Drug Enrichment in Rabbit Tissues Using HPLC-UV

机译:米托蒽醌负载的超顺磁性纳米粒子用于药物靶向:使用HPLC-UV定量测定兔组织中药物富集的一种多功能而灵敏的方法

获取原文

摘要

In medicine, superparamagnetic nanoparticles bound to chemotherapeutics are currently investigated for their feasibility in local tumor therapy. After intraarterial application, these particles can be accumulated in the targeted area by an external magnetic field to increase the drug concentration in the region of interest (Magnetic-Drug-Targeting). We here present an analytical method (HPLC-UV), to detect pure or ferrofluid-bound mitoxantrone in a complex matrix even in trace amounts in order to perform biodistribution studies. Mitoxantrone could be extracted in high yields from different tissues. Recovery of mitoxantrone in liver tissue (5000 ng/g) was76±2%. The limit of quantification of mitoxantrone standard was 10 ng/mL±12%. Validation criteria such as linearity, precision, and stability were evaluated in ranges achieving the FDA requirements. As shown for pilot samples, biodistribution studies can easily be performed after application of pure or ferrofluid-bound mitoxantrone.
机译:在医学上,目前正在研究与化学疗法结合的超顺磁性纳米粒子在局部肿瘤治疗中的可行性。在动脉内应用后,这些颗粒可以通过外部磁场聚集在目标区域中,以增加目标区域中的药物浓度(磁性-药物靶向)。我们在这里提出一种分析方法(HPLC-UV),以检测复杂基质中的纯或铁磁流体结合的米托蒽醌,甚至进行痕量检测,以进行生物分布研究。米托蒽醌可以高产量地从不同组织中提取。肝组织中米托蒽醌的回收率(5000 ng / g)为76±2%。米托蒽醌标准品的定量限为10 ng / mL±12%。在达到FDA要求的范围内评估了线性,精密度和稳定性等验证标准。如中试样品所示,在应用纯的或与铁磁流体结合的米托蒽醌后,可以轻松进行生物分布研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号